Diabetes drugs Actos and Competact suspended in France And Germany, potential bladder cancer risk (Medical News Today, 10 June 2011)

13 Jun 2011


Drug regulators in France and Germany have suspended the use of medicines containing pioglitazone whilst the drug's risk-benefit profile is reviewed. The regulators advise that patients must not stop taking these drugs without first checking with their doctor.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story